$ABBV---An Easy Way to Earn Big Biotech Returns Samuel Taube Photo By Samuel Taube Written Jun. 30, 2019 Bristol-Myers Squibb (NYSE: BMY) and Celgene (NASDAQ: CELG). Eli Lilly (NYSE: LLY) and Loxo Oncology (NASDAQ: LOXO).
And now AbbVie (NYSE: ABBV) and Allergan (NYSE: AGN). Big biotech mergers and acquisitions are happening left and right these days.
In the process, they’re driving big gains in the prices of the companies being acquired. Allergan stock jumped more than 35% after the announcement that AbbVie would try to buy it for $188.24 per share.